Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure
- 1 April 1983
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 25 (4), 339-384
- https://doi.org/10.2165/00003495-198325040-00002
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- COMPARISON OF THE VASODILATOR PRAZOSIN AND THE SELECTIVE BETA1 AGONIST PRENALTEROL ON REST AND EXERCISE HAEMODYNAMICS IN CHFActa Medica Scandinavica, 1981
- Competitive Blockade of α‐Adrenergic Receptors in Rat Heart by PrazosiActa Pharmacologica et Toxicologica, 1980
- Metabolic Effects of Chronic Prazosin TreatmentHormone and Metabolic Research, 1980
- Effects of Prazosin on Plasma Renin Activity and Blood PressureThe Journal of Clinical Pharmacology, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Cell Metabolism, 1979
- Effect of prazosin vs placebo on chronic left ventricular heart failure.Cell Metabolism, 1979
- Pharmacokinetics of Prazosin in ManThe Journal of Clinical Pharmacology, 1978
- PrazosinDrugs, 1977
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Cell Metabolism, 1977
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977